Barclays
BRLI

Barclays’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Barclays’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-19,600
Closed -$804K – 7369
2015
Q2 		$804K Sell
19,600
-69,700
-78% -$2.5M ﹤0.01% 3080
2015
Q1 		$3.13M Buy
89,300
+63,700
+249% +$2.16M ﹤0.01% 1929
2014
Q4 		$819K Buy
25,600
+15,100
+144% +$437K ﹤0.01% 3381
2014
Q3 		$294K Buy
10,500
+3,100
+42% +$94.4K ﹤0.01% 4413
2014
Q2 		$222K Sell
7,400
-9,700
-57% -$268K ﹤0.01% 4721
2014
Q1 		$462K Buy
17,100
+2,800
+20% +$73.3K ﹤0.01% 4040
2013
Q4 		$358K Buy
14,300
+6,400
+81% +$197K ﹤0.01% 4419
2013
Q3 		$229K Sell
7,900
-7,500
-49% -$209K ﹤0.01% 4911
2013
Q2 		$443K Buy
+15,400
New +$424K ﹤0.01% 4353

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Barclays's BRLI Position: Q3 2015 in Review

Barclays sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 47,438 shares — an estimated $1.94M sold.

Barclays first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $2.29M in Q3 2014. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Barclays reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Barclays sold 47,438 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $1.94M.
  • Barclays first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Barclays's BIO-REFERENCE LABS INC-NEW- position peaked at $2.29M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Barclays's 13F filing for Q3 2015, filed 13 Nov 2015.